Hubbard John W Insider Trades

Insider Trading History

Track insider trading activity for Hubbard John W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $0 0 shares
Last Trade
Aug 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.48k 976 shares
$1.52
$1.51
Science 37 Holdings
Science 37 Holdings SNCE
other, Former Director
Holding Value $0 0 shares
Last Trade
Mar 12, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$124k 21,573 shares
$5.75
$5.75
Science 37 Holdings
Science 37 Holdings SNCE
other, Former Director
Holding Value $0 0 shares
Last Trade
Mar 12, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$11.8k 2,050 shares
$5.75
$5.75
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $1.61k 1,065 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.81k 1,065 shares
$3.58
$1.51
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $0 0 shares
Last Trade
May 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$207k 40,983 shares
$5.05
$5.75
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $2.85M 494,853 shares
Last Trade
May 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 494,853 shares
$5.05
$5.75
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $236k 40,983 shares
Last Trade
May 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$207k 40,983 shares
$5.05
$5.75
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $1.22k 807 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.46M 807 shares
$3,050.00
$1.51
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $236k 40,983 shares
Last Trade
May 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 40,983 shares
$61.00
$5.75
LifeSci Acquisition II
LifeSci Acquisition II LSAQ
Director
Holding Value $248k 27,575 shares
Last Trade
Oct 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 27,575 shares
$10.05
$9.01
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $159k 27,575 shares
Last Trade
Oct 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.54M 27,575 shares
$201.00
$5.75
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $2.32M 403,896 shares
Last Trade
Oct 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.64M 403,896 shares
$9.01
$5.75
Science 37 Holdings
Science 37 Holdings SNCE
Director
Holding Value $292k 50,802 shares
Last Trade
Oct 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 50,802 shares
$9.01
$5.75
LifeSci Acquisition II
LifeSci Acquisition II LSAQ
Director
Holding Value $3.64M 403,896 shares
Last Trade
Oct 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.64M 403,896 shares
$9.01
$9.01
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $84.3k 55,852 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.58B 29,905 shares
$153,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $47.3k 31,342 shares
Last Trade
Jun 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.33B 22,606 shares
$280,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $113k 75,000 shares
Last Trade
Jun 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.73B 75,000 shares
$103,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $0 0 shares
Last Trade
Jun 08, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.1B 17,949 shares
$61,090.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $27.1k 17,949 shares
Last Trade
Jun 08, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.1B 17,949 shares
$61,090.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $75.5k 50,000 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.98B 50,000 shares
$59,690.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up